SONM — DNA X Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for DNA X, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -38.6 | -14.1 | -0.09 | -33.6 | -20.7 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 3.6 | 0.682 | 2.14 | 11.3 | -2.08 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.54 | -1.33 | -8.31 | 10.3 | -3.71 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -38.5 | -12.4 | -4.05 | -8.49 | -23.5 |
| Capital Expenditures | -0.046 | -0.008 | -0.036 | -0.214 | 0 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.046 | -0.008 | -0.036 | -0.214 | 0 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 27.6 | 14.3 | 0.272 | 4.65 | 19.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -10.9 | 1.98 | -3.82 | -4.05 | -4.04 |